Quantifying the burden of cardiac amyloid: The future is about numbers!

Dominik C Benz^{1

2

3

4}, Sharmila Dorbala^{2

3

4}, Aju P Pazhenkottil⁵

Affiliations

¹ Cardiac Imaging, Department of Cardiology and Nuclear Medicine, University Hospital Zurich, Raemistrasse 100, 8091, Zurich, Switzerland.
² CV Imaging Program, Cardiovascular Division, Department of Radiology, Brigham and Women's Hospital, Boston, MA, USA.
³ Amyloidosis Program, Division of Cardiology, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
⁴ Division of Nuclear Medicine, Department of Radiology, Brigham and Women's Hospital, Boston, MA, USA.
⁵ Cardiac Imaging, Department of Cardiology and Nuclear Medicine, University Hospital Zurich, Raemistrasse 100, 8091, Zurich, Switzerland. aju.pazhenkottil@usz.ch.

Editorial

Dominik C Benz et al. J Nucl Cardiol. 2023 Feb.

. 2023 Feb;30(1):112-115.

doi: 10.1007/s12350-022-03011-7. Epub 2022 Jun 7.

Dominik C Benz^{1

2

3

4}, Sharmila Dorbala^{2

3

4}, Aju P Pazhenkottil⁵

¹ Cardiac Imaging, Department of Cardiology and Nuclear Medicine, University Hospital Zurich, Raemistrasse 100, 8091, Zurich, Switzerland.
² CV Imaging Program, Cardiovascular Division, Department of Radiology, Brigham and Women's Hospital, Boston, MA, USA.
³ Amyloidosis Program, Division of Cardiology, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
⁴ Division of Nuclear Medicine, Department of Radiology, Brigham and Women's Hospital, Boston, MA, USA.
⁵ Cardiac Imaging, Department of Cardiology and Nuclear Medicine, University Hospital Zurich, Raemistrasse 100, 8091, Zurich, Switzerland. aju.pazhenkottil@usz.ch.

No abstract available

Comment on

Quantitative ^99mTc-DPD-SPECT/CT assessment of cardiac amyloidosis.
Kessler L, Fragoso Costa P, Kersting D, Jentzen W, Weber M, Lüdike P, Carpinteiro A, Oubari S, Hagenacker T, Thimm A, Rassaf T, Herrmann K, Papathanasiou M, Rischpler C. Kessler L, et al. J Nucl Cardiol. 2023 Feb;30(1):101-111. doi: 10.1007/s12350-022-02960-3. Epub 2022 May 13. J Nucl Cardiol. 2023. PMID: 35562639 Free PMC article.

1. Grogan M, Scott CG, Kyle RA, Zeldenrust SR, Gertz MA, Lin G. Natural history of wild-type transthyretin cardiac amyloidosis and risk stratification using a novel staging system. J Am Coll Cardiol 2016;68:1014‐20. - DOI - PubMed
1. Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M, et al. Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. N Engl J Med 2018;379:1007‐16. - DOI - PubMed
1. González-López E, Gallego-Delgado M, Guzzo-Merello G, de Haro-Del Moral FJ, Cobo-Marcos M, Robles C, et al. Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction. Eur Heart J 2015;36:2585‐94. - DOI - PubMed
1. Castaño A, Narotsky DL, Hamid N, Khalique OK, Morgenstern R, DeLuca A, et al. Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement. Eur Heart J 2017;38:2879‐87. - DOI - PubMed - PMC
1. Witteles RM, Bokhari S, Damy T, Elliott PM, Falk RH, Fine NM, et al. Screening for transthyretin amyloid cardiomyopathy in everyday practice. JACC Heart Fail 2019;7:709‐16. - DOI - PubMed